Dicerna Pharmaceutic (DRNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | DRNA | FOLD | IMCR | ||
| Company | Dicerna Pharmaceutic | Amicus Therapeutics | Immunocore Holdings Plc ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 38.21 | 10.26 | 57.75 | ||
| High | 38.24 | 10.32 | 58.94 | ||
| Low | 38.21 | 10.11 | 56.10 | ||
| Last | 38.22 | 10.28 | 58.46 | ||
| Change | +0.22 | +0.11 | +0.46 | ||
| % Change | +0.58% | +1.08% | +0.79% | ||
| Volume | 5,568,900 | 1,714,700 | 403,500 | ||
| 20-Day Average Volume | 3,647,665 | 2,747,880 | 446,440 | ||
| Previous Close | 38.00 | 10.17 | 58.00 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 38.03 | 10.97 | 58.54 | ||
| 20-Day Raw Stochastic | 90.72% | 14.44% | 45.60% | ||
| 20-Day Relative Strength | 80.40% | 35.87% | 45.15% | ||
| Weighted Alpha | +35.17 | -18.00 | -1.50 | ||
| Today's Opinion | 88% Buy | 80% Sell | 56% Sell | ||
| Previous Opinion | 72% Buy | 72% Sell | 56% Sell | ||
| Last Month's Opinion | 24% Buy | 56% Sell | 40% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.08% since 12/17/21 | -3.11% since 04/19/24 | +4.99% since 04/19/24 | ||
| Low | 37.81 on 12/21/21 | 10.02 on 04/25/24 | 55.54 on 04/22/24 | ||
| High | 38.24 on 12/27/21 | 10.93 on 04/23/24 | 59.41 on 04/25/24 | ||
| 1-Month | |||||
| %Chg | +0.61% since 11/26/21 | -10.06% since 03/26/24 | -5.19% since 03/26/24 | ||
| Low | 37.78 on 12/10/21 | 10.02 on 04/25/24 | 52.14 on 04/17/24 | ||
| High | 38.26 on 12/03/21 | 11.93 on 03/28/24 | 66.00 on 04/01/24 | ||
| 3-Month | |||||
| %Chg | +83.31% since 09/27/21 | -16.69% since 01/26/24 | -16.46% since 01/26/24 | ||
| Low | 19.06 on 10/06/21 | 10.02 on 04/25/24 | 52.14 on 04/17/24 | ||
| High | 38.26 on 12/03/21 | 14.03 on 02/15/24 | 76.98 on 02/01/24 | ||
| 6-Month | |||||
| %Chg | +1.95% since 06/25/21 | -5.34% since 10/26/23 | +27.34% since 10/26/23 | ||
| Low | 19.06 on 10/06/21 | 9.70 on 11/10/23 | 42.21 on 10/30/23 | ||
| High | 40.14 on 07/20/21 | 14.57 on 12/28/23 | 76.98 on 02/01/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 2,986,090 | 3,004,045 | 2,889,618 | ||
| Shares Outstanding, K | 78,129 | 295,383 | 49,821 | ||
| Annual Sales | 164,310,000 | 399,360,000 | 249,430,000 | ||
| Annual Net Income | -112,750,000 | -151,580,000 | -55,290,000 | ||
| Last Quarter Sales | 62,950,000 | 115,080,000 | 70,340,000 | ||
| Last Quarter Net Income | -17,070,000 | -33,840,000 | -19,790,000 | ||
| 60-Month Beta | 0.80 | 0.75 | 0.89 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A on 11/09/21 | -0.11 on 02/28/24 | -0.40 on 02/28/24 | ||
| Latest Earnings Date | 11/09/21 | 05/08/24 | 05/08/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||